Acute skeletal muscle loss in SARS‐CoV‐2 infection contributes to poor clinical outcomes in COVID‐19 patients
Open Access
- 19 July 2022
- journal article
- research article
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 13 (5) , 2436-2446
Abstract
Background: Chronic disease causes skeletal muscle loss that contributes to morbidity and mortality. There are limited data on the impact of dynamic muscle loss on clinical outcomes in COVID‐19. We hypothesized that acute COVID‐19‐related muscle loss (acute sarcopenia) is associated with adverse outcomes.Methods: A retrospective analysis of a prospective clinical registry of COVID‐19 patients was performed in consecutive hospitalized patients with acute COVID‐19 (n = 95) and compared with non‐COVID‐19 controls (n = 19) with two temporally unique CT scans. Pectoralis muscle (PM), erector spinae muscle (ESM) and 30 day standardized per cent change in cross sectional muscle area were quantified. Primary outcomes included mortality and need for intensive care unit (ICU) admission. Multivariate linear and logistic regression were performed. Cox proportional hazard ratios were generated for ICU admission or mortality for the per cent muscle loss standardized to 30 days.Results: The COVID‐19 CT scan cohort (n = 95) had an average age of 63.3 ± 14.3 years, comorbidities including COPD (28.4%) and diabetes mellitus (42.1%), and was predominantly Caucasian (64.9%). The proportion of those admitted to the ICU was 54.7%, with 10.5% requiring tracheostomy and overall mortality 16.8%. Median duration between CT scans was 32 days (IQR: 16–63 days). Significant reductions in median per cent loss was noted for PM (−2.64% loss [IQR: −0.28, −5.47] in COVID‐19 vs. −0.06 loss [IQR: −0.01, −0.28] in non‐COVID‐19 CT controls, P < 0.001) and ESM (−1.86% loss [IQR: −0.28, −5.47] in COVID‐19 vs. −0.06 loss [IQR: −0.02, −0.11]) in non‐COVID‐19 CT controls, P < 0.001). Multivariate linear regression analysis of per cent loss in PM was significantly associated with mortality (−10.8% loss [95% CI: −21.5 to −0.19]) and ICU admission (−11.1% loss [95% CI: −19.4 to −2.67]), and not significant for ESM. Cox proportional hazard ratios demonstrated greater association with ICU admission (adj HR 2.01 [95% CI: 1.14–3.55]) and mortality (adj HR 5.30 [95% CI: 1.19–23.6]) for those with significant per cent loss in PM, and greater association with ICU admission (adj HR 8.22 [95% CI: 1.11–61.04]) but not mortality (adj HR 2.20 [95% CI: 0.70–6.97]) for those with significant per cent loss in ESM.Conclusions: In a well‐characterized cohort of 95 hospitalized patients with acute COVID‐19 and two temporally distinct CT scans, acute sarcopenia, determined by standardized reductions in PM and ESM, was associated with worse clinical outcomes. These data lay the foundation for evaluating dynamic muscle loss as a predictor of clinical outcomes and targeting acute sarcopenia to improve clinical outcomes for COVID‐19.Keywords
Funding Information
- National Center for Advancing Translational Sciences (K08 AA028794, R21 AR 071046, 5U01 DK062470‐17S2, U01 DK061732, R56HL141744, U01 AA 026976, 3U01AA026976, R01 AA021890, P50 AA024333, R01 DK113196, R01 GM119174)
This publication has 40 references indexed in Scilit:
- Chest computed tomography-derived low fat-free mass index and mortality in COPDEuropean Respiratory Journal, 2017
- Sarcopenia from mechanism to diagnosis and treatment in liver diseaseJournal of Hepatology, 2016
- Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patientsJournal of Cachexia, Sarcopenia and Muscle, 2016
- Aging augments the impact of influenza respiratory tract infection on mobility impairments, muscle-localized inflammation, and muscle atrophyAging, 2016
- Quantitative Computed Tomography Measures of Pectoralis Muscle Area and Disease Severity in Chronic Obstructive Pulmonary Disease. A Cross-Sectional StudyAnnals of the American Thoracic Society, 2014
- Acute Skeletal Muscle Wasting in Critical IllnessJAMA, 2013
- Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary diseaseThe International Journal of Biochemistry & Cell Biology, 2013
- Protein Intake and Muscle Strength in Older Persons: Does Inflammation Matter?Journal of the American Geriatrics Society, 2012
- Youden Index and Optimal Cut‐Point Estimated from Observations Affected by a Lower Limit of DetectionBiometrical Journal, 2008
- Hypoxia Alters Iron Homeostasis and Induces Ferritin Synthesis in OligodendrocytesJournal of Neurochemistry, 1995